Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Sheehan

Showing results (121-130 of 195) with videos related to

Pageof 20
Sort By:
Acta Psychiatrica Scandinavica|July 1, 1993
The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled studyD V Sheehan, A B Raj, K Harnett-Sheehan, et al.
Research in Medical Education : Proceedings of the ... Annual Conference. Conference on Research in Medical Education|January 1, 1988
Substance use and abuse among senior medical students in 23 medical schoolsD C Baldwin, S Conard, P Hughes, et al.
Journal of Medical Education|October 1, 1988
Substance use by fourth-year students at 13 U.S. medical schoolsS Conard, P Hughes, D C Baldwin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 21, 2012
Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United StatesAnthony J Rothschild, Atul R Mahableshwarkar, Paula Jacobsen, et al.
Psychopharmacology Bulletin|January 1, 1987
Suriclone for generalized anxiety disorder: an escalating multiple-dose, safety, tolerance, and efficacy studyW E Falk, J F Rosenbaum, D V Sheehan, et al.
International Clinical Psychopharmacology|November 25, 2010
Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scaleDavid V Sheehan, Kathy Harnett-Sheehan, Melissa E Spann, et al.
The American Journal of Psychiatry|October 11, 1992
Resident physician substance use, by specialtyP H Hughes, D C Baldwin, D V Sheehan, et al.
The Journal of Clinical Psychiatry|May 1, 1985
Lactate infusion in anxiety research: its evolution and practiceD V Sheehan, D B Carr, S M Fishman, et al.
International Clinical Psychopharmacology|September 8, 2012
Evaluation of the effect of duloxetine treatment on functioning as measured by the Sheehan disability scale: pooled analysis of data from six randomized, double-blind, placebo-controlled clinical studiesMichele Mancini, David V Sheehan, Koen Demyttenaere, et al.
JAMA|April 24, 1991
Resident physician substance use in the United StatesP H Hughes, S E Conard, D C Baldwin, et al.
Pageof 20

Showing results (121-130 of 195) with videos related to

Sort By:
Pageof 20
Acta Psychiatrica Scandinavica|July 1, 1993
The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled studyD V Sheehan, A B Raj, K Harnett-Sheehan, et al.
Research in Medical Education : Proceedings of the ... Annual Conference. Conference on Research in Medical Education|January 1, 1988
Substance use and abuse among senior medical students in 23 medical schoolsD C Baldwin, S Conard, P Hughes, et al.
Journal of Medical Education|October 1, 1988
Substance use by fourth-year students at 13 U.S. medical schoolsS Conard, P Hughes, D C Baldwin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 21, 2012
Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United StatesAnthony J Rothschild, Atul R Mahableshwarkar, Paula Jacobsen, et al.
Psychopharmacology Bulletin|January 1, 1987
Suriclone for generalized anxiety disorder: an escalating multiple-dose, safety, tolerance, and efficacy studyW E Falk, J F Rosenbaum, D V Sheehan, et al.
International Clinical Psychopharmacology|November 25, 2010
Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scaleDavid V Sheehan, Kathy Harnett-Sheehan, Melissa E Spann, et al.
The American Journal of Psychiatry|October 11, 1992
Resident physician substance use, by specialtyP H Hughes, D C Baldwin, D V Sheehan, et al.
The Journal of Clinical Psychiatry|May 1, 1985
Lactate infusion in anxiety research: its evolution and practiceD V Sheehan, D B Carr, S M Fishman, et al.
International Clinical Psychopharmacology|September 8, 2012
Evaluation of the effect of duloxetine treatment on functioning as measured by the Sheehan disability scale: pooled analysis of data from six randomized, double-blind, placebo-controlled clinical studiesMichele Mancini, David V Sheehan, Koen Demyttenaere, et al.
JAMA|April 24, 1991
Resident physician substance use in the United StatesP H Hughes, S E Conard, D C Baldwin, et al.
Pageof 20